The U.S. market for OTCs has shown a compound annual growth rate of only 2.6% from 2011 through 2016. Most years during that five-year period the market have shown 3.0% or less year-over-year growth, with the exception of 2014 to 2015, when the market was up nearly 5.0%. This was largely driven by the return